Blockskye | $15,800,000 | (Jul 18, 2025)
Occupi | $3,000,000 | (Jul 18, 2025)
Receive | $4,000,000 | (Jul 18, 2025)
Certified by Founder
Lodge
Corsair Pharma
start up
United States
- Sunnyvale, California
- 22/09/2023
- Series B
- $23,000,000
Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company is focused on the development of novel prodrugs of treprostinil to treat patients with PAH using a once-daily transdermal patch.
- Industry Pharmaceutical Manufacturing
- Website https://www.corsairpharma.com/
- LinkedIn https://www.linkedin.com/company/corsairpharma/about/
Empirical Security | $12,000,000 | (Jul 18, 2025)
WattCarbon | Undisclosed Amount | (Jul 18, 2025)
StrongestLayer | $5,200,000 | (Jul 18, 2025)
Folio | $14,000,000 | (Jul 18, 2025)
Lo Foods | $3,500,000 | (Jul 18, 2025)
BQP(US) | $5,000,000 | (Jul 18, 2025)
TRIFFT Loyalty | $550,000 | (Jul 18, 2025)
One Biosciences | $17,382,375 | (Jul 17, 2025)
KNOT(INDIA) | $3,000,000 | (Jul 17, 2025)